Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04NDO
|
|||
| Former ID |
DNC010047
|
|||
| Drug Name |
4-(2-(2-fluorobenzyloxy)phenyl)piperidine
|
|||
| Synonyms |
CHEMBL573897; 4-(2-(2-fluorobenzyloxy)phenyl)piperidine
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C18H20FNO
|
|||
| Canonical SMILES |
C1CNCCC1C2=CC=CC=C2OCC3=CC=CC=C3F
|
|||
| InChI |
1S/C18H20FNO/c19-17-7-3-1-5-15(17)13-21-18-8-4-2-6-16(18)14-9-11-20-12-10-14/h1-8,14,20H,9-13H2
|
|||
| InChIKey |
CDVPUDLPRZVZHB-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1... Bioorg Med Chem Lett. 2009 Dec 1;19(23):6604-7. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.